SEPAR position paper on the use of high flow nasal cannula therapy in the home setting

Ver/Abrir
Identificadores
URI: https://hdl.handle.net/10902/37704
ISSN: 0300-2896
ISSN: 1579-2129
ISSN: 2173-5751
Compartir
Estadísticas
Ver Estadísticas
Google Scholar
Registro completo
Mostrar el registro completo DC
Autoría
Moreno-Zabaleta, Raúl; Luján, Manuel; Sayas Catalán, Javier; García Torres, Pedro; López-Padilla, Daniel; Mosteiro Añón, Mar; Martí Beltrán, Sergi; Sanz, Ana; González Martínez, MónicaAutoridad Unican; Mediano, Olga
Fecha
2025-04-26
Derechos
© 2025. This manuscript version is made available under the CC-BY-NC-ND 4.0 license.
Publicado en
Archivos de Bronconeumología, 2025, 010, 1-9
Editorial
Elsevier Doyma
Disponible después de
2026-05-01
Enlace a la publicación
Palabras clave
High flow nasal cannula therapy
High flow oxygen
Chronic use of high flow nasal cannula therapy
Domiciliary use of nasal cannula therapy
Resumen/Abstract
The purpose of this document is to establish SEPAR's official position on the use of high-flow nasal cannula (HFNC) therapy in the home management of patients with chronic respiratory diseases. This position statement is deemed necessary considering current evidence regarding HFNC use in chronic respiratory conditions, with the objective of standardizing its application. This consensus was developed by a panel of experts comprising specialists with established expertise in chronic respiratory failure and high-flow nasal cannula therapy. The panel of experts stablished recommendations in COPD, bronchiectasis, interstitial lung diseases, palliative care, rehabilitation, and chronic treatment settings.
Colecciones a las que pertenece
© 2025. This manuscript version is made available under the CC-BY-NC-ND 4.0 license.Excepto si se señala otra cosa, la licencia del ítem se describe como © 2025. This manuscript version is made available under the CC-BY-NC-ND 4.0 license.